Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension

This study investigated the safety and efficacy of the HyperQure™ extravascular renal denervation (RDN) system in a swine model of mild hypertension. Ten female pigs were fed a 3% salt diet to induce hypertension and underwent either extravascular RDN using the HyperQure™ RDN system (n = 7) or a sha...

Full description

Saved in:
Bibliographic Details
Main Authors: Jang Hee Han, Yerzhan Sharapatov, Minh-Tung Do, Sang Youn Kim, Bogyeong Han, Eue-Keun Choi, Chang Wook Jeong
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10641963.2025.2474520
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325972396965888
author Jang Hee Han
Yerzhan Sharapatov
Minh-Tung Do
Sang Youn Kim
Bogyeong Han
Eue-Keun Choi
Chang Wook Jeong
author_facet Jang Hee Han
Yerzhan Sharapatov
Minh-Tung Do
Sang Youn Kim
Bogyeong Han
Eue-Keun Choi
Chang Wook Jeong
author_sort Jang Hee Han
collection DOAJ
description This study investigated the safety and efficacy of the HyperQure™ extravascular renal denervation (RDN) system in a swine model of mild hypertension. Ten female pigs were fed a 3% salt diet to induce hypertension and underwent either extravascular RDN using the HyperQure™ RDN system (n = 7) or a sham procedure (n = 3). Blood pressure (BP) was continuously monitored using implanted transmitters, and safety assessments were conducted via computed tomography angiography (CTA) at 28 days post-procedure. The primary endpoint was the change in systolic blood pressure (SBP) at four weeks, while secondary endpoints included changes in diastolic BP (DBP), mean arterial pressure (MAP), and histological evaluation of renal nerve and artery integrity. At four weeks, SBP decreased by 11.8 ± 5.2 mmHg in the RDN group compared to an increase of 6.4 ± 4.2 mmHg in controls, resulting in a mean difference of 18.2 mmHg (p < .05). Similar improvements were observed in DBP and MAP, with mean differences of 15.4 and 16.2 mmHg, respectively (both p < .05). CTA revealed no significant renal artery or intraperitoneal organ injury. Histological analysis confirmed effective nerve ablation, as evidenced by reduced tyrosine hydroxylase staining, without intimal damage. No postoperative complications were observed during the 28-day study period. These findings demonstrate the safety and efficacy of the HyperQure™ extravascular RDN system in reducing BP, providing a promising alternative for patients with resistant hypertension or those ineligible for intravascular RDN. Further clinical trials are warranted to validate these results.
format Article
id doaj-art-8ce9950dce7e4ca69a29517da58ff68f
institution Kabale University
issn 1064-1963
1525-6006
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj-art-8ce9950dce7e4ca69a29517da58ff68f2025-08-20T03:48:15ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062025-12-0147110.1080/10641963.2025.2474520Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertensionJang Hee Han0Yerzhan Sharapatov1Minh-Tung Do2Sang Youn Kim3Bogyeong Han4Eue-Keun Choi5Chang Wook Jeong6Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDivision of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South KoreaThis study investigated the safety and efficacy of the HyperQure™ extravascular renal denervation (RDN) system in a swine model of mild hypertension. Ten female pigs were fed a 3% salt diet to induce hypertension and underwent either extravascular RDN using the HyperQure™ RDN system (n = 7) or a sham procedure (n = 3). Blood pressure (BP) was continuously monitored using implanted transmitters, and safety assessments were conducted via computed tomography angiography (CTA) at 28 days post-procedure. The primary endpoint was the change in systolic blood pressure (SBP) at four weeks, while secondary endpoints included changes in diastolic BP (DBP), mean arterial pressure (MAP), and histological evaluation of renal nerve and artery integrity. At four weeks, SBP decreased by 11.8 ± 5.2 mmHg in the RDN group compared to an increase of 6.4 ± 4.2 mmHg in controls, resulting in a mean difference of 18.2 mmHg (p < .05). Similar improvements were observed in DBP and MAP, with mean differences of 15.4 and 16.2 mmHg, respectively (both p < .05). CTA revealed no significant renal artery or intraperitoneal organ injury. Histological analysis confirmed effective nerve ablation, as evidenced by reduced tyrosine hydroxylase staining, without intimal damage. No postoperative complications were observed during the 28-day study period. These findings demonstrate the safety and efficacy of the HyperQure™ extravascular RDN system in reducing BP, providing a promising alternative for patients with resistant hypertension or those ineligible for intravascular RDN. Further clinical trials are warranted to validate these results.https://www.tandfonline.com/doi/10.1080/10641963.2025.2474520Blood pressuredenervationhypertensionlaparoscopy
spellingShingle Jang Hee Han
Yerzhan Sharapatov
Minh-Tung Do
Sang Youn Kim
Bogyeong Han
Eue-Keun Choi
Chang Wook Jeong
Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
Clinical and Experimental Hypertension
Blood pressure
denervation
hypertension
laparoscopy
title Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
title_full Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
title_fullStr Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
title_full_unstemmed Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
title_short Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
title_sort safety and efficacy of extravascular renal denervation using hyperqure™ renal denervation system in short term swine model of hypertension
topic Blood pressure
denervation
hypertension
laparoscopy
url https://www.tandfonline.com/doi/10.1080/10641963.2025.2474520
work_keys_str_mv AT jangheehan safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT yerzhansharapatov safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT minhtungdo safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT sangyounkim safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT bogyeonghan safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT euekeunchoi safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension
AT changwookjeong safetyandefficacyofextravascularrenaldenervationusinghyperqurerenaldenervationsysteminshorttermswinemodelofhypertension